About Arcensus
Arcensus is a company based in Rostock (Germany) founded in 2021 by Michael Schlenk and Arndt Rolfs was acquired by Dammam Valley in September 2022. Arcensus offers products and services including myLifeGenome, myLifeExome, and Data2Report. Arcensus operates in a competitive market with competitors including BodyClock, Molecular Life, GeneLinx, DNAid Diagnostics and Lia Health, among others.
- Headquarter Rostock, Germany
- Founders Michael Schlenk, Arndt Rolfs
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arcensus Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
MBG MV
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Dammam Valley
(Sep 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arcensus
Arcensus offers a comprehensive portfolio of products and services, including myLifeGenome, myLifeExome, and Data2Report.
Whole genome sequencing for personalized health insights.
Exome sequencing to identify rare genetic disorders.
Platform for generating and accessing clinical reports.
People of Arcensus
Unlock access to complete
Funding Insights of Arcensus
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Seed - Arcensus | Valuation |
investors |
Investors in Arcensus
Arcensus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include MBG MV and Dammam Valley.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Financial support is provided to SMEs in Mecklenburg-Vorpommern.
|
Founded Year | Domain | Location | |
|
Investment arm of Imam Abdulrahman Bin Faisal University, focused on future industries.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arcensus
Financial Statements - Arcensus
Arcensus Comparisons
Competitors of Arcensus
Arcensus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BodyClock, Molecular Life, GeneLinx, DNAid Diagnostics and Lia Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of RNA-based hair test for personalized sleep and lifestyle recommendations
|
|
| domain | founded_year | HQ Location |
Offers genetics-based personalized health recommendations.
|
|
| domain | founded_year | HQ Location |
Provides personalized genetic counseling and testing for health risks and family planning.
|
|
| domain | founded_year | HQ Location |
Operates a diagnostic lab for detecting cancer through blood tests.
|
|
| domain | founded_year | HQ Location |
An AI-based app designed for effective health management and monitoring.
|
Latest news on Arcensus
Frequently Asked Questions about Arcensus
Arcensus was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Arcensus is headquartered in Rostock, Germany. It is registered at Rostock, Mecklenburg-vorpommern, Germany.
Shivendra Kishore is the current CEO of Arcensus.
Arcensus was founded in 2021 in Rostock, Germany, within the genetic diagnostics sector. Test kits are provided for analyzing cardiac and cancer-related genes, including myLife Heart, myLife Cancer, and myLifeDNA. Medical counseling is delivered by professionals to support users. Operations focus on direct-to-consumer genetic testing services in Europe.
Arcensus's top competitors include BodyClock, Molecular Life and GeneLinx.
Arcensus offers myLifeGenome, myLifeExome, and Data2Report.
Arcensus has 2 investors. Key investors include MBG MV, and Dammam Valley.